Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
BlossomHill Therapeutics, Inc. (BLSM) had Normalized Income after Taxes of $-23.76M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-23.76M |
|
-- |
|
-- |
|
$24.67M |
|
$-24.67M |
|
$0.91M |
|
$-23.76M |
|
$-23.76M |
|
$-23.76M |
|
$-23.76M |
|
$-23.76M |
|
|
Normalized Income after Taxes |
$-23.76M |
$-24.67M |
|
$-24.55M |
|
2.71M |
|
2.71M |
|
$-8.75 |
|
$-8.75 |
|
| Balance Sheet Financials | |
$100.97M |
|
$1.49M |
|
$23.16M |
|
$124.13M |
|
$18.62M |
|
-- |
|
$23.47M |
|
$42.09M |
|
$-174.78M |
|
$82.04M |
|
$82.04M |
|
2.77M |
|
| Cash Flow Statement Financials | |
$-44.17M |
|
$-0.01M |
|
$2.88M |
|
$136.68M |
|
$95.38M |
|
$-41.31M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
13.59% |
|
-28.96% |
|
-19.14% |
|
-28.96% |
|
$29.64 |
|
$-16.28 |
|
$-16.28 |
|